Category: Uncategorized
MD Anderson’s Therapeutics Discovery division, Orionis Biosciences launch Project Helios to advance novel small-molecule cancer medicines
Orionis Biosciences and MD Anderson Cancer Center announce the launch of Project Helios, a research collaboration designed to unlock new drug development opportunities through genome-scale mapping of drug-target interactions….
Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets
March 5, 2020, Boston (MA, US), Ghent (Belgium) – Orionis Biosciences is today debuting with the announcement of a major drug discovery collaboration with Novartis. Orionis has developed innovative technologies in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities to tackle the industry’s most intractable disease targets. The goal of the…